Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREM1 in Radio-induced Mammary Fibrosis
NCT04948840Unknown
- Sponsor
- Centre François Baclesse
- Start
- Apr 2022
- Primary completion
- Dec 2024
- Countries
- 2
01
Overview
Open-label trial (5 arms), sponsored by Centre François Baclesse. Primary endpoint: Correlation of circulating TREM1 with presence or absence of early persistent radiation-induced epidermis at 2 years. Status: unknown.
Beyond the preview
Go deeper on NCT04948840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04948840.